Medpage Today on MSN3 个月
Overcoming the Challenges of Applying CAR T-Cell Therapy to Solid Tumors
Another BiTE in development by Amgen binds CD3 on ... have been evaluating a bivalent CAR T-cell therapy for recurrent ...